ASERTI is focused on designing new small molecule therapeutics that capture disease-related proteins during translation, leading to their degradation. This new ‘SERTI’ mechanism will soon address a wide variety of protein-driven diseases.
Company Details
- Founded
- 2025
- Address
- A Wide Variety Of Protein-Driven Diseases.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aserti.bio
- Keywords
- AnaSpec.
Aserti Pharmaceutical Questions
Aserti Pharmaceutical's website is http://www.aserti.bio
Aserti Pharmaceutical's LinkedIn profile is https://www.linkedin.com/company/aserti-pharmaceutical
Aserti Pharmaceutical's industry is
Biotechnology Research
Aserti Pharmaceutical's top competitors are
Novo Nordisk Foundation Center For Stem Cell Medicine – Renew,
Qbn,
Vectory,
Evenly Technologies,
Anaspec,
Crescenta Biosciences Inc.,
Mineralys Therapeutics, Inc.,
Araya Inc.,
Sironax,
Bni Networking Professionals.
Aserti Pharmaceutical's categories are Biotechnology Research
Aserti Pharmaceutical's founding year is 2025
